Taxotere (docataxel), a chemotherapy drug commonly used in breast cancer treatment in Philadelphia, has been found to cause permanent alopecia or hair loss. Taxotere is more toxic and more potent than other similar treatments, but there is no evidence the drug is more effective. Countless Philadelphia breast cancer patients consented to Taxotere treatment without knowledge of the possible side effect of permanent hair loss. Taxotere hair loss is a traumatic experience, which can result in psychological distress, body image problems, and ongoing suffering and depression.
Though Philadelphia breast cancer patients and their doctors were not aware of the risk of permanent hair loss from Taxotere, the drug's manufacturer, Sanofi, apparently was. By 2005, Sanofi executives were in possession of study results indicating that Taxotere hair loss was suffered as a side effect by 9% of patients. Sanofi issued Taxotere hair loss warnings to consumers in Canada and Europe. In the Philadelphia and throughout the United States, permanent alopecia or hair loss was not listed as a possible Taxotere side effect.
Rather than warning Philadelphia consumers about the potential for permanent hair loss from Taxotere, the company continued its aggressive marketing campaigns to promote off-label uses of Taxotere. An illegal scheme, Sanofi's strategy of providing incentives to doctors who prescribed Taxotere for off-label uses resulted in significant revenue increases. Between 2000 and 2004, Taxotere's sales rose from $424 million to $1.4 billion. The drug was also promoted for its "super efficacy", though no study results ever indicated Taxotere to be more effective than other, safer chemotherapy drugs. Sanofi directly caused countless Philadelphia residents to be exposed to Taxotere permanent hair loss and other side effects.
For its fraudulent promotion of Taxotere, Sanofi has been the subject of FDA warnings and regulation. However, the company has not yet been held accountable for causing permanent Taxotere alopecia in thousands of Philadelphia patients. Filing a Philadelphia Taxotere hair loss lawsuit is the primary means for individual consumers in Philadelphia to hold Sanofi accountable for its fraudulent and despicable actions. Philadelphia Taxotere hair loss lawsuits can result in real compensation for persons who have suffered from Taxotere side effects. Persons and the family members of persons in Philadelphia who have suffered permanent hair loss from Taxotere are eligible for a free case review with a Philadelphia Taxotere attorney.
If you or a loved one in Philadelphia has suffered from permanent hair loss as a result of exposure to Taxotere, you may have legal grounds to file a Philadelphia Taxotere hair loss lawsuit against Sanofi. Philadelphia Taxotere lawsuits give individuals in Philadelphia a means to pursue justice and obtain compensation for the physical harm and mental anguish associated with unanticipated permanent hair loss from Taxotere.
Hair loss has been documented as the most distressing side effect of chemotherapy; persons in Philadelphia who have suffered permanent hair loss describe an ongoing mental anguish and damage to their body image. Even after recovering from cancer, permanent hair loss makes a person feel like a cancer patient for life. Our lawyers believe that persons in Philadelphia who were harmed by Taxotere through no fault of their own deserve compensation for their suffering.
Led to believe their hair would regrow, countless Philadelphia breast cancer patients underwent Taxotere chemotherapy. Little did they know, a safety study funded by Sanofi detected the risk for permanent hair loss in 2005. Furthermore, an alternative treatment has been available that promises similar or even better outcomes without the risk of permanent Taxotere hair loss.
While consumers in Europe and Canada were warned of the danger of Taxotere hair loss, Philadelphia patients were not. Only very recently did the FDA add permanent alopecia or hair loss to its list of Taxotere side effects. Sanofi executives intentionally chose not to warn Americans about the risk of Taxotere hair loss, meanwhile garnering billions in sales. It is the mission of our attorneys handling Philadelphia Taxotere lawsuits to pursue justice on behalf of these persons and their families harmed by Taxotere in Philadelphia.
Sanofi, a major multinational pharmaceutical company originating from France, sells Taxotere in the United States, Canada and Europe. Sanofi received FDA approval to market Taxotere for use in treating breast cancer in 1996. Evidence suggests the company launched a marketing campaign at that time aimed at promoted Taxotere for off-label uses. A former Sanofi employee has accused the company of paying illegal kickbacks and bonuses to physicians for prescribing the drug for uses other than those which the FDA approved. In 2009, and FDA warning letter was issued regarding Taxotere, citing false advertising claims which were not backed by science. Through misbranding and deceit, the company has directly caused thousands of cancer patients to be exposed to a risk for permanent hair loss from Taxotere, meanwhile reaping the profits of major global sales of the drug.
For companies willing to forgo consumer safety in the name of profit margins, the threat of major litigation is often the only method to advance corporate accountability for safety. Short cuts in premarket testing and negligence toward safety standards become business strategies. To some extent, litigation is seen as a cost of doing business to these large corporations, and harming some patients along the way seems inevitable. Filing a Philadelphia Taxotere hair loss lawsuit can help individuals in Philadelphia recover the compensation they deserve, and also serves to hold Sanofi accountable for its disregard for consumer safety.
Our attorneys handling Philadelphia Taxotere lawsuits are currently offering free case review with no further obligation. To speak with an lawyer handling Philadelphia Taxotere hair loss lawsuit claims, use our online chat feature or complete the contact form on this site. One of our attorneys serving Philadelphia will contact you promptly to discuss your situation and answer your questions at no charge.
Philadelphia Taxotere hair loss lawsuits will not be class action lawsuits in which claimants should anticipate only a small, symbolic settlement. Instead, it is likely that Philadelphia Taxotere lawsuits against Sanofi will be consolidated as Multidistrict Litigation (MDL). MDL is a legal procedure that enables many parallel claims to be resolved at once, while keeping intact the unique details that set each case apart. In resolving multidistrict litigation, compensation is determined on an individual basis, accounting for the degree of suffering experienced by each claimant. MDL unifies consumers harmed by a common drug or medical device in order to advance justice and demand corporate accountability.
We will represent all persons involved in a Philadelphia Taxotere lawsuit against Sanofi on a contingency basis, meaning our attorneys never charge legal fees unless we win compensation in your case. To access your free, no-obligation Philadelphia Taxotere case review please contact our firm; one of our Philadelphia Taxotere hair loss lawyers will answer your questions and give you their assessment of your legal options.
Making the decision to file a Philadelphia Taxotere hair loss lawsuit is significant, and choosing the best lawyer for yourself can be challenging. Whether you choose to work with our firm or not, we believe the information on this page will be of use as you make your decision. Being informed about your legal options is the first step toward pursuing justice in your case. This page offers answers to common Philadelphia Taxotere lawsuit questions which will apply to most Philadelphia Taxotere hair loss lawsuit claims. For more detailed information, please contact our firm for a free, no-obligation Philadelphia Taxotere lawsuit consultation.
The lawyers handling Philadelphia Taxotere hair loss claims at The Onder Law Firm are experts in the arena of dangerous drug litigation, pursuing justice on behalf of Philadelphia families harmed by Taxotere. Philadelphia Taxotere hair loss lawyers endeavor to hold the maker responsible for the damage and harm the product has caused among countless Philadelphia consumers, and for its negligence in providing warning information the company possessed.
These Philadelphia Taxotere attorneys specialize in representing individuals and families in product liability lawsuits, pursuing justice against large corporations whose dangerous or defective products have harmed consumers. It is our belief that the safety of American consumers should always come first. When a large multi-national pharmaceutical company is profiting to the detriment of Philadelphia consumers, our Taxotere attorneys serving Philadelphia see it as their duty to achieve justice and hold negligent companies accountable.
With the resources of a large, successful firm that has won settlements on behalf of clients in every major pharmaceutical litigation of late, these Philadelphia Taxotere lawyers are prepared to dedicate the significant resources needed to win even the most complex of cases. When corporations benefit at the cost of consumer safety, our Philadelphia Taxotere attorneys see it as their duty to achieve justice and hold negligent companies accountable.
If you or someone you love has experienced permanent Taxotere hair loss in Philadelphia, you may be eligible for significant compensation through filing a claim. Hair loss is listed as the most distressing side effect of chemotherapy, but the side effect is typically limited to the time period a patient undergoes treatment. Permanent hair loss is unexpected; therefore, persons being exposed to Taxotere had a right to be warned about the risk for permanent hair loss in order to make an informed decision. Contact our firm to access your free, no-obligation case review with an experienced Philadelphia Taxotere hair loss lawyer.
Taxotere became available in Philadelphia in 1996, and quickly became a mainstay for breast cancer treatment. At its height, Taxotere garnered more than $1.4 billion in annual sales. Today we know the widespread use of Taxotere was more the result of misleading advertising and illegal drug promotion than the drug's superiority; in fact, other drugs have been found to be equally or more effective, and less toxic than Taxotere.
Taxotere was not adequately tested for safety prior to market release. When Sanofi did learn of the danger of Taxotere permanent hair loss, the company chose not to warn American consumers of the risk. Countless Philadelphia breast cancer patients were exposed to the danger for Taxotere hair loss without their knowledge. Many Philadelphia physicians are now choosing alternate drugs that are less toxic that Taxotere. Our Philadelphia Taxotere hair loss attorneys believe Sanofi must be held accountable for its blatant disregard of consumer safety.
Working on behalf of Philadelphia individuals harmed Taxotere permanent hair loss, these Philadelphia Taxotere lawyers will work tirelessly for justice no matter how complex the case. Taxotere lawsuits in Philadelphia endeavor to win real compensation for the ongoing suffering and distress resulting from Taxotere permanent hair loss.
These Philadelphia Taxotere hair loss attorneys provide legal representation on a contingency basis, meaning you will never pay any legal fees unless we win compensation in your case. For a free no-obligation consultation please contact the firm and one of the Philadelphia Taxotere lawyers handling permanent hair loss cases in Philadelphia will contact you to answer any of your questions.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.